[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Pages 31390-31391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12821]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Sigma Aldrich Research Biochemicals, Inc.

    By Notice dated January 26, 2012, and published in the Federal 
Register on February 6, 2012, 77 FR 5847, Sigma Aldrich Research 
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-
2447, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
4-methyl-N-methylcathinone (1248)................  I
Aminorex (1585)..................................  I
Alpha-ethyltryptamine (7249).....................   I
Lysergic acid diethylamide (7315)................  I
3,4-methylenedioxypyrovalerone (7535)............  I
3,4-methylenedioxy-N-methylcathinone (7540)......  I
Tetrahydrocannabinols (7370).....................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......  I
2,5-Dimethoxyamphetamine (7396)..................  I
3,4-Methylenedioxyamphetamine (7400).............  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
Psilocybin (7437)................................  I

[[Page 31391]]

 
5-Methoxy-N,N-diisopropyltryptamine (7439).......  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).....  I
N-Benzylpiperazine (7493)........................  I
Heroin (9200)....................................  I
Normorphine (9313)...............................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Nabilone (7379)..................................  II
1-Phenylcyclohexylamine (7460)...................  II
Phencyclidine (7471).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Diprenorphine (9058).............................  II
Ecgonine (9180)..................................  II
Levomethorphan (9210)............................  II
Levorphanol (9220)...............................  II
Meperidine (9230)................................  II
Metazocine (9240)................................  II
Methadone (9250).................................  II
Morphine (9300)..................................  II
Thebaine (9333)..................................  II
Levo-alphacetylmethadol (9648)...................  II
Remifentanil (9739)..............................  II
Sufentanil (9740)................................  II
Carfentanil (9743)...............................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Sigma Aldrich Research Biochemicals, Inc. to manufacture the listed 
basic classes of controlled substances is consistent with the public 
interest at this time. DEA has investigated Sigma Aldrich Research 
Biochemicals, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12821 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P